Saturday, March 15, 2025 | 10:20 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Human trials for Covid-19 vaccine may begin in 6 months: ICMR Official

"The virus strain isolated at the National Institute of Virology (NIV) laboratory in Pune will be used to develop the vaccine"

coronavirus, test
Premium

Kant insisted the focus should be on five per cent to 10 per cent serious patients

IANS New Delhi
As India ranked 10th in the global infection list, overtaking Iran, which was an early hotspot of coronavirus, India's top medical body has said the human trials of Covid-19 vaccine may begin at least in six months.

Speaking to IANS, Dr. Rajni Kant, Director Regional Medical Research Centre and Head at the Indian Council of Medical Research (ICMR) said, "The virus strain isolated at the National Institute of Virology (NIV) laboratory in Pune will be used to develop the vaccine, and this strain has been successfully transferred to the Bharat Biotech International Ltd. (BBIL). It is expected that the human
Topics : Coronavirus

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in